Regulation of fibronectin gene expression by cyclic AMP and phorbol myristate acetate in HT-1080 human fibrosarcoma cells

Exp Mol Med. 1998 Dec 31;30(4):240-5. doi: 10.1038/emm.1998.35.

Abstract

We studied the regulation of fibronectin (FN) gene expression by cAMP and phorbol-12-myristate-13-acetate (PMA) in HT-1080 human fibrosarcoma cells. Dibutyryl cAMP increased FN synthesis and mRNA levels, while PMA inhibited the cAMP-induced FN synthesis. In transient transfection assays, cAMP increased FN promoter activity, while PMA paradoxically enhanced the cAMP-induced promoter activity. Stable transfection experiments, however, showed that neither cAMP or PMA alone nor together affected FN promoter activity. These results suggest that PMA antagonizes the cAMP-induced FN gene expression and that both the action of cAMP and the inhibition of its action by PMA may occur at the posttranscriptional level in HT-1080 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Northern
  • Bucladesine / antagonists & inhibitors
  • Bucladesine / pharmacology*
  • Enzyme-Linked Immunosorbent Assay
  • Fibronectins / genetics*
  • Fibronectins / metabolism
  • Fibrosarcoma / genetics*
  • Gene Expression Regulation*
  • Humans
  • Luciferases / metabolism
  • Precipitin Tests
  • Promoter Regions, Genetic
  • RNA, Messenger / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Transfection
  • Tumor Cells, Cultured
  • beta-Galactosidase / metabolism

Substances

  • Fibronectins
  • RNA, Messenger
  • Bucladesine
  • Luciferases
  • beta-Galactosidase
  • Tetradecanoylphorbol Acetate